TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33026515

Group type: EXPERIMENTAL
Intervention: Preferred music
Number of subjects: 97

Group type: COMPARATOR
Intervention: Operating room noise
Number of subjects: 97
Study: 36228569

Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus rhamnosus GG (LGG)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study: 32719011

Group type: EXPERIMENTAL
Intervention: Non-menthol cigarettes
Number of subjects: 122

Group type: COMPARATOR
Intervention: Menthol cigarettes
Number of subjects: 122
Study: 34973303

Group type: EXPERIMENTAL
Intervention: Continuous intra-incisional bupivacaine
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (no bupivacaine)
Number of subjects: 31
Study: 33444359

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (150 minutes per week for 52 weeks)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Education control intervention
Number of subjects: 117
Study: 33744933

Group type: EXPERIMENTAL
Intervention: Daprodustat
Number of subjects: 2964

Group type: COMPARATOR
Intervention: Epoetin alfa or darbepoetin alfa
Number of subjects: 2964
Study: 34554694

Group type: EXPERIMENTAL
Intervention: Pulsed Radiofrequency (PRF) treatment of the saphenous nerve
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo treatment (sham procedure with motor stimulation)
Number of subjects: 70
Study: 33801688

Group type: EXPERIMENTAL
Intervention: Fish oil emulsion enriched with omega-3 fatty acids
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sunflower oil emulsion containing omega-6 fatty acids
Number of subjects: 58
Study: 32121066

Group type: EXPERIMENTAL
Intervention: 1 g of Undaria pinnatifida fucoidan (UPF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34448986

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (Headspace)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 116
Study: 34138672

Group type: EXPERIMENTAL
Intervention: FIFA 11+ Shoulder Injury Prevention Program (FIFA 11+S) performed before all training sessions for 1 season (6 months)
Number of subjects: 726

Group type: COMPARATOR
Intervention: Usual routine warm‐up program before training sessions for 1 season
Number of subjects: 726

Group type: EXPERIMENTAL
Intervention: FIFA 11+S program
Number of subjects: 726
Study: 32323904

Group type: EXPERIMENTAL
Intervention: FMR with lyophilized growth factors
Number of subjects: 25

Group type: COMPARATOR
Intervention: FMR with saline (placebo)
Number of subjects: 25
Study: 35720066

Group type: EXPERIMENTAL
Intervention: Safinamide (50 mg/day for 2 weeks and 100 mg/day for 22 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Safinamide (post-hoc analysis)
Number of subjects: 30
Study: 36367004

Group type: EXPERIMENTAL
Intervention: Nalbuphine 10 mg and sufentanil (NS1)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Nalbuphine 10 mg and sufentanil 20 mg (NS2)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Nalbuphine 30 mg and sufentanil 20 mg (NS3)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Sufentanil (S)
Number of subjects: 160
Study: 32030525

Group type: EXPERIMENTAL
Intervention: Game Changers intervention
Number of subjects: 99
Study: 35912157

Group type: EXPERIMENTAL
Intervention: DEX+general anesthesia
Number of subjects: 90
Study: 33471169

Group type: EXPERIMENTAL
Intervention: Intranasal sodium citrate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (untreated left nasal cavity)
Number of subjects: 60
Study: 32487465

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (N = 18)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Hatha yoga (N = 21)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Waitlist group (N = 12)
Number of subjects: 51
Study: 35634851

Group type: EXPERIMENTAL
Intervention: Viltolarsen
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (matched historical control group)
Number of subjects: 16
Study: 35078536

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Oriented Recovery Enhancement (MORE) intervention
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-intervention control group
Number of subjects: 64
Study: 32694705

Group type: EXPERIMENTAL
Intervention: Non-pharmaceutical dry eye therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Daily saline eye wash
Number of subjects: 0
Study: 36076295

Group type: EXPERIMENTAL
Intervention: Communities That Heal (CTH) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study: 33930408

Group type: EXPERIMENTAL
Intervention: Teprotumumab (8 infusions every 3 weeks)
Number of subjects: 170
Study: 35795940

Group type: EXPERIMENTAL
Intervention: Brisk walking group (Group C)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Static control group (Group A)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Walking group (Group B)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Jogging group (Group D)
Number of subjects: 131
Study: 34059039

Group type: EXPERIMENTAL
Intervention: Hem-o-lok clips
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Endoloop
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Endostapler
Number of subjects: 180

Group type: COMPARATOR
Intervention: All study arms
Number of subjects: 180
Study: 34979212

Group type: EXPERIMENTAL
Intervention: MRI-guided prostate SBRT (40 Gy/5 fractions)
Number of subjects: 20
Study: 32002650

Group type: COMPARATOR
Intervention: 4-aminopyridine for the symptomatic treatment of episodic ataxia type 2 and downbeat nystagmus
Number of subjects: 0
Study: 35329124

Group type: EXPERIMENTAL
Intervention: Resistance training with one-minute inter-set rest under HH
Number of subjects: 16

Group type: COMPARATOR
Intervention: Resistance training with two-minute inter-set rest under HH
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Resistance training with one-minute inter-set rest under NH
Number of subjects: 16

Group type: COMPARATOR
Intervention: Resistance training with two-minute inter-set rest under NH
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Resistance training under HH
Number of subjects: 16

Group type: COMPARATOR
Intervention: Resistance training under NH
Number of subjects: 16
Study: 33177622

Group type: COMPARATOR
Intervention: BAFF (B cell activating factor) levels in EBV+ patients
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: In vitro experiments with BAFF on EBV-infected B cells
Number of subjects: 540

Group type: COMPARATOR
Intervention: B cell expansion in vivo among EBV+ patients
Number of subjects: 540

Group type: COMPARATOR
Intervention: Inter-correlations of soluble factors in EBV+ patients
Number of subjects: 540
Study: 615413969

Group type: EXPERIMENTAL
Intervention: Sertraline plus thrice-weekly progressive aerobic exercise (S+PAE)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Sertraline plus thrice-weekly non-progressive exercise (S+NPE)
Number of subjects: 121
Study: 34941317

Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) for treatment planning (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clinician-guided treatment planning (n = 20)
Number of subjects: 40
Study: 34365067

Group type: EXPERIMENTAL
Intervention: exhalatory-gated RAVANS (e-RAVANS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: inhalatory-gated RAVANS (i-RAVANS)
Number of subjects: 20
Study: 33185375

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided suprascapular nerve block (US-guided SSNB)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Landmark-guided suprascapular nerve block (landmark-guided SSNB)
Number of subjects: 72
Study: 34937846

Group type: EXPERIMENTAL
Intervention: National Career Coach Program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Local Community Resources
Number of subjects: 0
Study: 32853783

Group type: EXPERIMENTAL
Intervention: Coffee (3 cups postoperatively at 6, 12, or 18 hours)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control (warm water)
Number of subjects: 96
Study: 33211928

Group type: COMPARATOR
Intervention: Advice by mail alone
Number of subjects: 9803

Group type: EXPERIMENTAL
Intervention: Targeted exercise in addition to advice by mail
Number of subjects: 9803

Group type: EXPERIMENTAL
Intervention: Multifactorial fall prevention in addition to advice by mail
Number of subjects: 9803
Study: 35835477

Group type: EXPERIMENTAL
Intervention: Kilkari messages (up to 72 messages)
Number of subjects: 5095

Group type: EXPERIMENTAL
Intervention: Kilkari messages
Number of subjects: 5095
Study: 33839105

Group type: COMPARATOR
Intervention: Activity-based training (ABT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Robotic locomotor training (RLT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Robotic locomotor training (RLT) and activity‐based training (ABT)
Number of subjects: 16
Study: 35692368

Group type: EXPERIMENTAL
Intervention: Virtual case-based auscultation course via video chat
Number of subjects: 55

Group type: COMPARATOR
Intervention: Literature self-study
Number of subjects: 55
Study: 33596181

Group type: EXPERIMENTAL
Intervention: TransLife mobile health app
Number of subjects: 16
Study: 36117259

Group type: EXPERIMENTAL
Intervention: Group CBT
Number of subjects: 5

Group type: COMPARATOR
Intervention: Individual CBT
Number of subjects: 5
Study: 34871006

Group type: EXPERIMENTAL
Intervention: Web-based OurRelationship program
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Web-based ePREP program
Number of subjects: 742

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 742
Study: 35220340

Group type: EXPERIMENTAL
Intervention: Glutamine supplementation
Number of subjects: 1021
Study: 33060472

Group type: EXPERIMENTAL
Intervention: C-loop haptic toric IOL (AcrySof Toric IOL)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Plate-haptic toric IOL (AT TORBI 709M IOL)
Number of subjects: 62
Study: 36167785

Group type: EXPERIMENTAL
Intervention: Labour inspection visits
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Guidance-through-workshops
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study: 33484027

Group type: EXPERIMENTAL
Intervention: Ivabradine plus conventional treatment (IG)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional treatment alone (CG)
Number of subjects: 35
Study: 36399476

Group type: EXPERIMENTAL
Intervention: Community-based bilingual doula support (CBD)
Number of subjects: 164
Study: 616824722

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic surgery (VATS) lobectomy
Number of subjects: 600

Group type: COMPARATOR
Intervention: Lobectomy using thoracotomy
Number of subjects: 600
Study: 33385766

Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) 100 mg/day
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 35064595

Group type: EXPERIMENTAL
Intervention: Response adaptive (RA) design intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed proportion design (control)
Number of subjects: 0
Study: 33978693

Group type: EXPERIMENTAL
Intervention: Question prompt list brochure (intervention)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 213
Study: 32910709

Group type: COMPARATOR
Intervention: 50 Gy in 25 fractions (n = 937)
Number of subjects: 1882

Group type: EXPERIMENTAL
Intervention: 40 Gy in 15 fractions (n = 917)
Number of subjects: 1882
Study: 35124395

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 1917

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1917
Study: 33960924

Group type: EXPERIMENTAL
Intervention: 2.32% Diclofenac Sodium Phonophoresis (DSPH)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1.16% Diclofenac Sodium Phonophoresis (DSPH)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Therapeutic Ultrasound (TUS)
Number of subjects: 90
Study: 34068195

Group type: EXPERIMENTAL
Intervention: High-intensity training (additional face-to-face training)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Low-intensity training (provision with materials and online training)
Number of subjects: 65
Study: 32017660

Group type: EXPERIMENTAL
Intervention: Modified cross‐body stretch (MCS)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Modified sleeper stretch (MSS)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (treatment program consisting of only modalities, range of motion [ROM], and strength training but no PSSEs)
Number of subjects: 67
Study: 34674834

Group type: EXPERIMENTAL
Intervention: Lower oxygenation target (8 kPa)
Number of subjects: 2888

Group type: COMPARATOR
Intervention: Higher oxygenation target (12 kPa)
Number of subjects: 2888
Study: 33068819

Group type: COMPARATOR
Intervention: 0.2 % chlorhexidine (CHX) for 5 min (positive control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Phycocyanin alone with ×2 MIC concentration for 5 min
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diode laser alone (635 nm wavelength, 220 mW power)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PDT with diode laser and phycocyanin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Negative control with no treatment
Number of subjects: 30
Study: 33022318

Group type: EXPERIMENTAL
Intervention: Motivationally-tailored, computer-assisted counseling intervention
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control condition (toll-free quitline)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 360
Study: 35676803

Group type: COMPARATOR
Intervention: Sacubitril/valsartan
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sacubitril/valsartan + Sitagliptin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Valsartan alone
Number of subjects: 12
Study: 33469832

Group type: EXPERIMENTAL
Intervention: Vibegron 75 mg once daily
Number of subjects: 1463

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1463

Group type: COMPARATOR
Intervention: Tolterodine 4 mg extended release
Number of subjects: 1463
Study: 32179445

Group type: EXPERIMENTAL
Intervention: Care pathway including QoL-profiles consisting of 13 QoL scales plus specific therapeutic recommendations forwarded to the patient's coordinating practitioner (CP)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Standard postoperative care adhering to the German national guideline for colorectal cancer (control)
Number of subjects: 220
Study: 34750334

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control with SBP < 120 mmHg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative blood pressure control as per JNC-8 guidelines
Number of subjects: 0
Study: 34081749

Group type: EXPERIMENTAL
Intervention: Childhood non-victims of emotional abuse
Number of subjects: 1929

Group type: EXPERIMENTAL
Intervention: Victims of mild emotional abuse
Number of subjects: 1929

Group type: EXPERIMENTAL
Intervention: Childhood non-victims of physical abuse
Number of subjects: 1929

Group type: EXPERIMENTAL
Intervention: Victims of mild physical abuse
Number of subjects: 1929

Group type: COMPARATOR
Intervention: Childhood experiences of severe emotional abuse
Number of subjects: 1929

Group type: COMPARATOR
Intervention: Childhood experiences of severe physical abuse
Number of subjects: 1929
Study: 34353994

Group type: EXPERIMENTAL
Intervention: Preoperative immunonutrition plus a normal diet
Number of subjects: 176
Study: 33427772

Group type: EXPERIMENTAL
Intervention: HA hydrogel
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 192
Study: 32009091

Group type: EXPERIMENTAL
Intervention: Lenalidomide plus dexamethasone (15 mg in cycle 1, 25 mg in cycles 2-6, dexamethasone 20 mg once a week)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Lenalidomide plus dexamethasone
Number of subjects: 5
Study: 35584433

Group type: EXPERIMENTAL
Intervention: 16-week aerobic and resistance training
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Baseline in-trial GFR
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Baseline ABI
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Lower ABI
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Higher systolic blood pressure
Number of subjects: 128
Study: 33453514

Group type: EXPERIMENTAL
Intervention: Exercise therapy (ET) 3 times/week for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: No-attention control group (CG)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Exercise therapy (ET)
Number of subjects: 60
Study: 35775544

Group type: EXPERIMENTAL
Intervention: Community lay counselors, self-help groups (SHGs), and trained frontline health workers for 2 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34335819

Group type: EXPERIMENTAL
Intervention: Garlic tablets (400 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 60
Study: 35386698

Group type: EXPERIMENTAL
Intervention: Genetically predicted increased BMI
Number of subjects: 14802

Group type: EXPERIMENTAL
Intervention: IL-6 signaling
Number of subjects: 14802

Group type: EXPERIMENTAL
Intervention: Higher BMI
Number of subjects: 14802

Group type: EXPERIMENTAL
Intervention: IL-6 signaling after adjusting for BMI
Number of subjects: 14802

Group type: EXPERIMENTAL
Intervention: Higher BMI after adjustment for IL-6 signaling
Number of subjects: 14802

Group type: EXPERIMENTAL
Intervention: Effect of BMI on MS mediated by IL-6 signaling
Number of subjects: 14802
Study: 34768722

Group type: EXPERIMENTAL
Intervention: Novel influenza vaccine with continuous monitoring using a wearable sensor.
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Random Forest classifier model applied to physiological data.
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Physiological data from the first and second day.
Number of subjects: 116
Study: 32124136

Group type: EXPERIMENTAL
Intervention: Normal BMD
Number of subjects: 1860

Group type: EXPERIMENTAL
Intervention: Osteopenia
Number of subjects: 1860

Group type: EXPERIMENTAL
Intervention: Osteoporosis
Number of subjects: 1860

Group type: EXPERIMENTAL
Intervention: Bisphosphonate use
Number of subjects: 1860
Study: 34323455

Group type: EXPERIMENTAL
Intervention: Transforaminal Epidural Steroid Injection (TFESI)
Number of subjects: 302
Study: 35060097

Group type: EXPERIMENTAL
Intervention: Muscle Shortening Manoeuvre (MSM)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Simple traction
Number of subjects: 24
Study: 33752390

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg once daily)
Number of subjects: 3730

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3730
Study: 35947150

Group type: EXPERIMENTAL
Intervention: Tympanoplasty with mastoidectomy (G1 group)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Tympanoplasty only (G2 group)
Number of subjects: 51
Study: 33634738

Group type: EXPERIMENTAL
Intervention: SIT (sprint interval training)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: HIIT (high-intensity interval training)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: MICT (moderate-intensity continuous training)
Number of subjects: 66

Group type: COMPARATOR
Intervention: CON (non-exercise control)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: All training groups
Number of subjects: 66
Study: 32035124

Group type: EXPERIMENTAL
Intervention: Implementation strategies including patient coaching, automated texting, peer phone support, academic detailing and audit and feedback for the patient's clinician.
Number of subjects: 0
Study: 35489367

Group type: EXPERIMENTAL
Intervention: ENO Breathe programme
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study: 34941126

Group type: EXPERIMENTAL
Intervention: Multi-disciplinary intervention program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33535811

Group type: EXPERIMENTAL
Intervention: Experimental COVID-19 vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active comparator vaccine
Number of subjects: 0
Study: 32097103

Group type: EXPERIMENTAL
Intervention: Agility training performed in the form of competitive exercising (experimental group)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard agility training (control group)
Number of subjects: 22
Study: 33865923

Group type: EXPERIMENTAL
Intervention: Exercise without dyslipidemia (EG/n = 11)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Exercise with dyslipidemia (EGD/n = 24)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control with dyslipidemia (CGD/n = 22)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control without dyslipidemia (CG/n = 13)
Number of subjects: 70
Study: 34210242

Group type: EXPERIMENTAL
Intervention: Co-supplementation group (n = 27): 50000 IU vitamin D soft gel weekly + 250 mg magnesium tablet daily
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Vitamin D group (n = 27): 50000 IU vitamin D soft gel weekly + magnesium placebo daily
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Magnesium group (n = 27): vitamin D placebo weekly + 250 mg magnesium tablet daily
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (n = 27): vitamin D placebo weekly + magnesium placebo daily
Number of subjects: 108
Study: 34274608

Group type: EXPERIMENTAL
Intervention: PERF-FIT Moving cans balance score
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: PERF-FIT static balance score
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Balance Sensory score
Number of subjects: 74
Study: 33301040

Group type: EXPERIMENTAL
Intervention: Interdisciplinary pain management program for chronic musculoskeletal pain
Number of subjects: 103
Study: 33019856

Group type: EXPERIMENTAL
Intervention: Testing of symptomatic and asymptomatic patients in building zero
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Testing of asymptomatic patients in building zero
Number of subjects: 65

Group type: COMPARATOR
Intervention: Testing of randomly selected asymptomatic patients from the rest of the hospital
Number of subjects: 65
Study: 33657442

Group type: EXPERIMENTAL
Intervention: Alcoholic drink (0.6 g/kg)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Alcoholic drink (0.3 g/kg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 84
Study: 32893106

Group type: EXPERIMENTAL
Intervention: Dorsal nerve relocation (DNR)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Dorsal neurectomy (DN)
Number of subjects: 47